The Filings Report

Centene Corporation

CNCNYSECIK 1071739Healthcare / Healthcare Plansfiscal year ends December70 quarters since 2009

Revenue, Q3 FY2026
$50.6B
+1.9% on Q3 FY2025
Net income
−$71M
+98.9% on Q3 FY2025
Free cash flow
−$3.9B
−437.4% on Q3 FY2025
Diluted EPS
$-0.14
+99.0% on Q3 FY2025
Revenue, TTM
$203.9B
trailing four quarters
Net margin, TTM
0.7%
net income $1.5B
Free cash flow, TTM
$3.9B
$4.7B less $781M capex
Cash and equivalents
$20.7B
long-term debt $15.5B, Sep 30, 2026
Shares, 12-month change
+0.7%
495M shares, Sep 30, 2026
Buybacks, TTM
$59M
0.2% of market value
Dividends, TTM
—
no yield
Market value
$33.9B
at the close, buybacks

Latest quarter Q3 FY2026, filed October 27, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Centene Corporation reported revenue of $50.6B, +1.9% on Q3 FY2025, and net loss of $71M (+98.9%). Net income this quarter is driven by non-operating items: $185M of other income against −$307M of operating income, so it reflects gains or losses outside the operations. Operating margin was −0.6%. Free cash flow, operating cash flow less capital expenditures, was −$3.9B (−$3.7B less $194M). Diluted earnings per share were $-0.14.

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of October 27, 2026.

Revenue and net incomeRevenueNet income
−$20B$0$20B$40B$60BQ4'22, Revenue: $35.6BQ4'22, Net income: −$213MQ4'22Q1'23, Revenue: $38.9BQ1'23, Net income: $1.1BQ1'23Q2'23, Revenue: $37.6BQ2'23, Net income: $1.1BQ2'23Q3'23, Revenue: $38.0BQ3'23, Net income: $469MQ3'23Q4'23, Revenue: $39.5BQ4'23, Net income: $45MQ4'23Q1'24, Revenue: $40.4BQ1'24, Net income: $1.2BQ1'24Q2'24, Revenue: $39.8BQ2'24, Net income: $1.1BQ2'24Q3'24, Revenue: $42.0BQ3'24, Net income: $713MQ3'24Q4'24, Revenue: $40.8BQ4'24, Net income: $283MQ4'24Q1'25, Revenue: $46.6BQ1'25, Net income: $1.3BQ1'25Q2'25, Revenue: $48.7BQ2'25, Net income: −$253MQ2'25Q3'25, Revenue: $49.7BQ3'25, Net income: −$6.6BQ3'25Q4'25, Revenue: $49.7BQ4'25, Net income: −$1.1BQ4'25Q1'26, Revenue: $49.9BQ1'26, Net income: $1.5BQ1'26Q2'26, Revenue: $53.6BQ2'26, Net income: $1.1BQ2'26Q3'26, Revenue: $50.6BQ3'26, Net income: −$71MQ3'26−$20B$0$20B$40B$60BQ4'22, Revenue: $35.6BQ4'22, Net income: −$213MQ1'23, Revenue: $38.9BQ1'23, Net income: $1.1BQ1'23Q2'23, Revenue: $37.6BQ2'23, Net income: $1.1BQ3'23, Revenue: $38.0BQ3'23, Net income: $469MQ3'23Q4'23, Revenue: $39.5BQ4'23, Net income: $45MQ1'24, Revenue: $40.4BQ1'24, Net income: $1.2BQ1'24Q2'24, Revenue: $39.8BQ2'24, Net income: $1.1BQ3'24, Revenue: $42.0BQ3'24, Net income: $713MQ3'24Q4'24, Revenue: $40.8BQ4'24, Net income: $283MQ1'25, Revenue: $46.6BQ1'25, Net income: $1.3BQ1'25Q2'25, Revenue: $48.7BQ2'25, Net income: −$253MQ3'25, Revenue: $49.7BQ3'25, Net income: −$6.6BQ3'25Q4'25, Revenue: $49.7BQ4'25, Net income: −$1.1BQ1'26, Revenue: $49.9BQ1'26, Net income: $1.5BQ1'26Q2'26, Revenue: $53.6BQ2'26, Net income: $1.1BQ3'26, Revenue: $50.6BQ3'26, Net income: −$71MQ3'26

Net income losses drawn in red.

Free cash flow
−$5B−$3B$0$3B$5BQ4'22, Free cash flow: −$1.8BQ4'22Q1'23, Free cash flow: $4.0BQ1'23Q2'23, Free cash flow: $2.3BQ2'23Q3'23, Free cash flow: $885MQ3'23Q4'23, Free cash flow: −$6MQ4'23Q1'24, Free cash flow: −$607MQ1'24Q2'24, Free cash flow: $2.0BQ2'24Q3'24, Free cash flow: −$1.1BQ3'24Q4'24, Free cash flow: −$741MQ4'24Q1'25, Free cash flow: $1.4BQ1'25Q2'25, Free cash flow: $1.6BQ2'25Q3'25, Free cash flow: $1.1BQ3'25Q4'25, Free cash flow: $224MQ4'25Q1'26, Free cash flow: $4.2BQ1'26Q2'26, Free cash flow: $3.4BQ2'26Q3'26, Free cash flow: −$3.9BQ3'26−$5B−$3B$0$3B$5BQ4'22, Free cash flow: −$1.8BQ1'23, Free cash flow: $4.0BQ1'23Q2'23, Free cash flow: $2.3BQ3'23, Free cash flow: $885MQ3'23Q4'23, Free cash flow: −$6MQ1'24, Free cash flow: −$607MQ1'24Q2'24, Free cash flow: $2.0BQ3'24, Free cash flow: −$1.1BQ3'24Q4'24, Free cash flow: −$741MQ1'25, Free cash flow: $1.4BQ1'25Q2'25, Free cash flow: $1.6BQ3'25, Free cash flow: $1.1BQ3'25Q4'25, Free cash flow: $224MQ1'26, Free cash flow: $4.2BQ1'26Q2'26, Free cash flow: $3.4BQ3'26, Free cash flow: −$3.9BQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$10B$20B$30BQ4'22, Cash and equivalents: $12.1BQ4'22, Long-term debt: $17.9BQ4'22Q1'23, Cash and equivalents: $15.9BQ1'23, Long-term debt: $18.2BQ1'23Q2'23, Cash and equivalents: $17.2BQ2'23, Long-term debt: $17.9BQ2'23Q3'23, Cash and equivalents: $18.2BQ3'23, Long-term debt: $17.9BQ3'23Q4'23, Cash and equivalents: $17.2BQ4'23, Long-term debt: $17.7BQ4'23Q1'24, Cash and equivalents: $17.6BQ1'24, Long-term debt: $17.9BQ1'24Q2'24, Cash and equivalents: $17.6BQ2'24, Long-term debt: $17.5BQ2'24Q3'24, Cash and equivalents: $14.6BQ3'24, Long-term debt: $17.5BQ3'24Q4'24, Cash and equivalents: $14.1BQ4'24, Long-term debt: $18.4BQ4'24Q1'25, Cash and equivalents: $14.8BQ1'25, Long-term debt: $18.3BQ1'25Q2'25, Cash and equivalents: $14.5BQ2'25, Long-term debt: $17.6BQ2'25Q3'25, Cash and equivalents: $17.1BQ3'25, Long-term debt: $17.5BQ3'25Q4'25, Cash and equivalents: $17.9BQ4'25, Long-term debt: $17.4BQ4'25Q1'26, Cash and equivalents: $21.3BQ1'26, Long-term debt: $16.3BQ1'26Q2'26, Cash and equivalents: $24.2BQ2'26, Long-term debt: $16.0BQ2'26Q3'26, Cash and equivalents: $20.7BQ3'26, Long-term debt: $15.5BQ3'26$0$10B$20B$30BQ4'22, Cash and equivalents: $12.1BQ4'22, Long-term debt: $17.9BQ1'23, Cash and equivalents: $15.9BQ1'23, Long-term debt: $18.2BQ1'23Q2'23, Cash and equivalents: $17.2BQ2'23, Long-term debt: $17.9BQ3'23, Cash and equivalents: $18.2BQ3'23, Long-term debt: $17.9BQ3'23Q4'23, Cash and equivalents: $17.2BQ4'23, Long-term debt: $17.7BQ1'24, Cash and equivalents: $17.6BQ1'24, Long-term debt: $17.9BQ1'24Q2'24, Cash and equivalents: $17.6BQ2'24, Long-term debt: $17.5BQ3'24, Cash and equivalents: $14.6BQ3'24, Long-term debt: $17.5BQ3'24Q4'24, Cash and equivalents: $14.1BQ4'24, Long-term debt: $18.4BQ1'25, Cash and equivalents: $14.8BQ1'25, Long-term debt: $18.3BQ1'25Q2'25, Cash and equivalents: $14.5BQ2'25, Long-term debt: $17.6BQ3'25, Cash and equivalents: $17.1BQ3'25, Long-term debt: $17.5BQ3'25Q4'25, Cash and equivalents: $17.9BQ4'25, Long-term debt: $17.4BQ1'26, Cash and equivalents: $21.3BQ1'26, Long-term debt: $16.3BQ1'26Q2'26, Cash and equivalents: $24.2BQ2'26, Long-term debt: $16.0BQ3'26, Cash and equivalents: $20.7BQ3'26, Long-term debt: $15.5BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed October 27, 2026.

Centene Corporation income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 27, 2026Q2 FY2026ended Jun 30, 2026filed Jul 28, 2026Q1 FY2026ended Mar 31, 2026filed Apr 28, 2026Q4 FY2025ended Dec 31, 2025filed Feb 17, 2026Q3 FY2025ended Sep 30, 2025filed Oct 29, 2025Q2 FY2025ended Jun 30, 2025filed Jul 25, 2025Q1 FY2025ended Mar 31, 2025filed Apr 25, 2025Q4 FY2024ended Dec 31, 2024filed Feb 18, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue50,64753,57949,94449,72549,69048,74246,62040,805+1.9%
Cost of revenue675729702680651641698688+3.7%
Gross profit3,3024,6175,6502,5583,3453,0185,2883,799−1.3%
Research and development—————————
Selling, general and administrative3,2353,1033,3973,3703,1453,0363,3533,231+2.9%
Operating income(307)1,1981,861(1,745)(6,954)(458)1,534175+95.6%
Other income (expense)185288238202280201212172−33.9%
Pretax income(122)1,4862,099(1,543)(6,674)(257)1,746347+98.2%
Income tax(57)399560(443)(42)243267−35.7%
Net income(71)1,0911,541(1,101)(6,631)(253)1,311283+98.9%
Diluted EPS ($)(0.14)2.193.11—(13.50)(0.51)2.63—+99.0%
Diluted shares (millions)494498496—491494498——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed October 27, 2026.

Centene Corporation balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 27, 2026Q2 FY2026ended Jun 30, 2026filed Jul 28, 2026Q1 FY2026ended Mar 31, 2026filed Apr 28, 2026Q4 FY2025ended Dec 31, 2025filed Feb 17, 2026Q3 FY2025ended Sep 30, 2025filed Oct 29, 2025Q2 FY2025ended Jun 30, 2025filed Jul 25, 2025Q1 FY2025ended Mar 31, 2025filed Apr 25, 2025Q4 FY2024ended Dec 31, 2024filed Feb 18, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents20,70024,15121,26417,88817,05814,51314,81514,063+21.4%
Short-term investments2,8862,9062,4772,4322,1792,7682,4722,622+32.4%
Total current assets45,46146,68544,98940,37044,06240,38941,28837,999+3.2%
Total assets79,28083,01281,17576,74782,08786,39587,04482,445−3.4%
Total current liabilities39,06840,75940,04536,71840,63036,78637,14334,261−3.8%
Long-term debt15,45416,03016,30817,35117,54517,55218,30818,423−11.9%
Total liabilities56,97360,35559,64856,69161,03258,89259,02555,935−6.7%
Stockholders’ equity22,20722,56221,42719,95320,94827,40627,91626,410+6.0%
Shares outstanding (millions)495494494492492491498496—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed October 27, 2026.

Centene Corporation cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 27, 2026Q2 FY2026ended Jun 30, 2026filed Jul 28, 2026Q1 FY2026ended Mar 31, 2026filed Apr 28, 2026Q4 FY2025ended Dec 31, 2025filed Feb 17, 2026Q3 FY2025ended Sep 30, 2025filed Oct 29, 2025Q2 FY2025ended Jun 30, 2025filed Jul 25, 2025Q1 FY2025ended Mar 31, 2025filed Apr 25, 2025Q4 FY2024ended Dec 31, 2024filed Feb 18, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow(3,669)3,5904,3664371,3561,7851,510(587)−370.6%
Capital expenditures194174200213211208135154−8.1%
Free cash flow (CFO − capex)(3,863)3,4164,1662241,1451,5771,375(741)−437.4%
Depreciation and amortization299300300329317315314314−5.7%
Share repurchases244292043241943—
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 17, 2026.

Income statement

Centene Corporation income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 17, 2026FY2024ended Dec 31, 2024filed Feb 18, 2025FY2023ended Dec 31, 2023filed Feb 20, 2024FY2022ended Dec 31, 2022filed Feb 21, 2023FY2021ended Dec 31, 2021filed Feb 22, 2022FY2020ended Dec 31, 2020filed Feb 22, 2021FY2019ended Dec 31, 2019filed Feb 18, 2020FY2018ended Dec 31, 2018filed Feb 19, 2019FY2017ended Dec 31, 2017filed Feb 20, 2018FY2016ended Dec 31, 2016filed Feb 21, 2017FY2015ended Dec 31, 2015filed Feb 22, 2016FY2014ended Dec 31, 2014filed Feb 23, 2015FY2013ended Dec 31, 2013filed Feb 21, 2014FY2012ended Dec 31, 2012filed Feb 19, 2013FY2011ended Dec 31, 2011filed Feb 21, 2012FY2010ended Dec 31, 2010filed Feb 22, 2011FY2009ended Dec 31, 2009filed Jul 27, 2010FY2008ended Dec 31, 2008filed Jul 27, 2010
Revenue194,777163,071153,999144,547125,982111,11574,63960,11648,38240,60722,76016,56010,8638,1105,2114,4484,1033,365
Cost of revenue2,6702,7293,5647,0324,8943,3032,4652,3861,8471,864————————
Gross profit14,20917,06917,63716,91814,487—————————————
Research and development——————————————————
Selling, general and administrative12,90412,40012,56311,5899,6019,3806,5336,0434,4463,6731,8021,298931677578478448445
Operating income(7,623)3,1752,9301,3181,7843,0821,7811,4581,1991,263705464277108204157138132
Other income (expense)8951,0826686448194804432531901143528193513151622
Pretax income(6,728)4,2573,5981,9621,8132,7731,7821,3681,1341,160697457269123188154138137
Income tax(51)9638997604779794734743265993391961074771604952
Net income(6,674)3,3052,7021,2021,3471,8081,3219008285623552711652111958483
Diluted EPS ($)(13.53)6.314.952.072.283.123.142.262.341.711.44*1.13*0.73*0.01*0.53*0.47*0.47*0.47*
Diluted shares (millions)493524546582591579420399353328246*241*225*215*210*202*177*178*

Balance sheet

Centene Corporation balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 17, 2026FY2024ended Dec 31, 2024filed Feb 18, 2025FY2023ended Dec 31, 2023filed Feb 20, 2024FY2022ended Dec 31, 2022filed Feb 21, 2023FY2021ended Dec 31, 2021filed Feb 22, 2022FY2020ended Dec 31, 2020filed Feb 22, 2021FY2019ended Dec 31, 2019filed Feb 18, 2020FY2018ended Dec 31, 2018filed Feb 19, 2019FY2017ended Dec 31, 2017filed Feb 20, 2018FY2016ended Dec 31, 2016filed Feb 21, 2017FY2015ended Dec 31, 2015filed Feb 22, 2016FY2014ended Dec 31, 2014filed Feb 23, 2015FY2013ended Dec 31, 2013filed Feb 21, 2014FY2012ended Dec 31, 2012filed Feb 19, 2013FY2011ended Dec 31, 2011filed Feb 21, 2012FY2010ended Dec 31, 2010filed Feb 22, 2011FY2009ended Dec 31, 2009filed Jul 27, 2010FY2008ended Dec 31, 2008filed Jul 27, 2010
Cash and equivalents17,88814,06317,19312,07413,11810,80012,1235,3424,0723,9301,7601,610974746574434404379
Short-term investments2,4322,6222,4592,3211,5391,5808637225315051761771021381302140—
Total current assets40,37037,99940,75630,12828,49723,39320,32311,9988,7038,3653,6052,9511,8001,406940657616—
Total assets76,74782,44584,64176,87078,37568,71940,99430,90121,85520,1977,3395,8243,5192,7742,1901,9441,702—
Total current liabilities36,71834,26136,71628,46425,76521,58512,93211,9719,3328,6233,6292,9001,5591,229838765716—
Long-term debt17,35118,42317,71017,93818,57116,68213,6386,6484,6954,6511,216874666535348328307—
Total liabilities56,69155,93558,68552,63351,35342,75728,30219,87814,97914,1435,0153,9332,2861,8201,2541,1471,083—
Stockholders’ equity19,95326,41025,84024,05726,79525,77312,55110,9176,8505,8952,1571,7441,234953936794601—
Shares outstanding (millions)492496535551583582587413347*344*243*238*230*209*204*209*——

Cash flow statement

Centene Corporation cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 17, 2026FY2024ended Dec 31, 2024filed Feb 18, 2025FY2023ended Dec 31, 2023filed Feb 20, 2024FY2022ended Dec 31, 2022filed Feb 21, 2023FY2021ended Dec 31, 2021filed Feb 22, 2022FY2020ended Dec 31, 2020filed Feb 22, 2021FY2019ended Dec 31, 2019filed Feb 18, 2020FY2018ended Dec 31, 2018filed Feb 19, 2019FY2017ended Dec 31, 2017filed Feb 20, 2018FY2016ended Dec 31, 2016filed Feb 21, 2017FY2015ended Dec 31, 2015filed Feb 22, 2016FY2014ended Dec 31, 2014filed Feb 23, 2015FY2013ended Dec 31, 2013filed Feb 21, 2014FY2012ended Dec 31, 2012filed Feb 19, 2013FY2011ended Dec 31, 2011filed Feb 21, 2012FY2010ended Dec 31, 2010filed Feb 22, 2011FY2009ended Dec 31, 2009filed Jul 27, 2010FY2008ended Dec 31, 2008filed Jul 27, 2010
Operating cash flow5,0881548,0536,2614,2055,5031,4831,2341,4891,8516581,223382279262169248222
Capital expenditures7676447991,0049108697306754223061501036882741192465
Free cash flow (CFO − capex)4,321(490)7,2545,2573,2954,6347535591,0671,5455081,12031419718850224157
Depreciation and amortization1,2751,2411,2931,4301,3351,25964349536127811189676658524435
Share repurchases4753,1241,6333,096297626757165635329191383624
Dividends paid——————————————————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$7M
2 sales by 1 insider; officers and directors $7M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$15M
5 sales by 2 insiders; officers and directors $15M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 15, 2026Carson Michael AGroup President, Medicare&Spectax withholding7,130$70.16$500K115,752Oct 15, 2026
Sep 30, 2026Tyler Lauren MDirectoraward482$0.00—3,698Sep 30, 2026
Sep 30, 2026Tanji KennethDirectoraward603$0.00—13,093Sep 30, 2026
Sep 30, 2026Samuels Theodore R. IIDirectoraward583$0.00—25,796Sep 30, 2026
Sep 30, 2026Eppinger Frederick HDirectoraward864$0.00—370,402Sep 30, 2026
Sep 30, 2026Coughlin Christopher JDirectoraward583$0.00—19,294Sep 30, 2026
Sep 15, 2026Pienkos Theodore JCorporate Controller & CAOtax withholding1,092$69.41$76K28,751Sep 16, 2026
Aug 26, 2026Koster ChristopherSecretary & General Counselopen-market sale56,500$66.90$4M248,854Aug 27, 2026
Aug 18, 2026Koster ChristopherSecretary & General Counselopen-market sale47,603$65.36$3M305,354Aug 19, 2026
Jul 28, 2026Diaz Paul JDirectoraward2,771$0.00—2,771Jul 28, 2026
Jul 17, 2026Tyler Lauren MDirectoraward3,155$0.00—3,216Jul 20, 2026
Jun 30, 2026Tyler Lauren MDirectoraward61$0.00—61Jul 1, 2026
Jun 30, 2026Tanji KennethDirectoraward581$0.00—12,490Jul 1, 2026
Jun 30, 2026Samuels Theodore R. IIDirectoraward465$0.00—25,213Jul 1, 2026
Jun 30, 2026Eppinger Frederick HDirectoraward833$0.00—369,538Jul 1, 2026
Jun 30, 2026Coughlin Christopher JDirectoraward562$0.00—18,711Jul 1, 2026
Jun 15, 2026Smith Susan RayeChief Operating Officertax withholding483$65.19$31K212,237Jun 15, 2026
Jun 10, 2026Burdick Kenneth ADirectoropen-market sale80,000$64.55$5M197,086Jun 11, 2026
May 12, 2026Tanji KennethDirectoraward3,992$0.00—11,909May 13, 2026
May 12, 2026Samuels Theodore R. IIDirectoraward3,992$0.00—24,748May 13, 2026
May 12, 2026Ford Monte EDirectoraward3,992$0.00—14,827May 13, 2026
May 12, 2026Eppinger Frederick HDirectoraward6,654$0.00—368,705May 13, 2026
May 12, 2026Dallas H JamesDirectoraward3,992$0.00—47,874May 13, 2026
May 12, 2026Coughlin Christopher JDirectoraward3,992$0.00—18,149May 13, 2026
May 12, 2026Burdick Kenneth ADirectoraward3,992$0.00—277,086May 13, 2026

Full insider history for Centene Corporation, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held CNC in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded CNC by quarter.

FundManagerQuarterValueSharesWeightMove
Greenlight CapitalDavid EinhornQ2 2026$106M2M2.71%trimmed −39.6%

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
CENTENE CORPORATION, CIK 1071739 on EDGAR
Extract generated
October 28, 2026
Withheld
1 line-years whose four quarters do not sum to the filed year: revenue FY2011
Repaired
1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2022
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: not filed
Selling, general and administrative: GeneralAndAdministrativeExpense, SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): InvestmentIncomeNonoperating, OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: not filed

The data

The statements on this page as files, generated October 28, 2026.

JSON file
/data/financials/CNC.json